CrossCare Compare Countries™

Compare Asian healthcare options

Select up to four destinations. Where CrossCare has no verified information, the comparison says so rather than filling the gap.

Destinations (4/4)

Destination Fit Scores are decision-support tools, not medical recommendations. Final treatment decisions require review by qualified healthcare professionals.

Cancer🇯🇵 Japan74%🇨🇳 Mainland China78%🇭🇰 Hong Kong80%🇸🇬 Singapore81%
Clinical matchStrong (92/100 · Verified structure)Strong (90/100 · Verified structure)Strong (87/100 · Verified structure)Strong (88/100 · Verified structure)
Relevant technologyStrong (95/100 · Verified structure)Strong (89/100 · Verified structure)Strong (87/100 · Verified structure)Strong (89/100 · Verified structure)
Provider optionsGood (70/100 · Verified structure)Good (74/100 · Verified structure)Strong (88/100 · Verified structure)Strong (92/100 · Verified structure)
Estimated cost positionLimited (46/100 · Estimated)Good (74/100 · Estimated)Limited (46/100 · Estimated)Limited (38/100 · Estimated)
Waiting timeModerate (62/100 · Estimated)Good (82/100 · Estimated)Strong (85/100 · Estimated)Strong (86/100 · Estimated)
Visa readinessLimited (48/100 · Verified structure)Limited (52/100 · Verified structure)Moderate (58/100 · Verified structure)Moderate (60/100 · Verified structure)
Language supportModerate (60/100 · Verified structure)Moderate (62/100 · Verified structure)Strong (93/100 · Verified structure)Strong (95/100 · Verified structure)
Travel simplicityModerate (62/100 · Verified structure)Moderate (66/100 · Verified structure)Good (84/100 · Verified structure)Good (82/100 · Verified structure)
Second opinion accessModerate (65/100 · Verified structure)Moderate (68/100 · Verified structure)Strong (91/100 · Verified structure)Strong (94/100 · Verified structure)
Insurance compatibilityModerate (62/100 · Verified structure)Moderate (60/100 · Verified structure)Strong (90/100 · Verified structure)Strong (88/100 · Verified structure)
Recovery supportGood (78/100 · Verified structure)Good (80/100 · Verified structure)Good (78/100 · Verified structure)Good (80/100 · Verified structure)
Continuity of careGood (80/100 · Verified structure)Good (74/100 · Verified structure)Strong (85/100 · Verified structure)Strong (86/100 · Verified structure)
Hospital-specific quotationAwaiting provider responseAwaiting provider responseAwaiting provider responseAwaiting provider response
Key limitations
  • Entry pathway for your passport is likely to need earlier and fuller documentation.
  • Interpretation is usually required — most clinical teams work in Japanese.
  • A medical coordinator is normally required by the receiving institution.
  • Entry pathway for your passport is likely to need earlier and fuller documentation.
  • Translation of records and on-site interpretation are normally required.
  • Cellular therapy access is programme-specific and must be verified case by case.
  • Entry pathway for your passport is likely to need earlier and fuller documentation.
  • Private treatment cost is high relative to most of Asia.
  • Complex inpatient capacity is smaller than in larger regional systems.
  • Highest anticipated treatment and accommodation cost in this comparison.
  • Hospitals commonly require financial guarantees before admission.
  • Extended stays add materially to the total journey cost.